Insight journal - Company

Ranbaxy: Partnering activity 2009-2014

Posted on 03 February 2014

Tags: , , ,

Ranbaxy, a research based big pharma company with its headquarters in India, has announced 14 partnering / licensing deals since 2009, with 5 deals in 2010 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in dermatology therapy focus.

Abstracted from: Report: Partnering Agreements with Ranbaxy 2009-2014

The number of partnering and collaboration deals announced varied year on year with a peak in 2010.

The following figure shows the level of Ranbaxy partnering deal announcements since 2009.

Figure 1: Ranbaxy partnering deals 2009-2014

Figure 1: Ranbaxy partnering deals 2009-2014

Figure 1: Ranbaxy partnering deals 2009-2014

 Source: Current Agreements, 2014

Analysis of the partnering deals shows a strong emphasis on partnerships in the dermatology disease area. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Report: Partnering Agreements with Ranbaxy 2009-2014

Figure 2: Ranbaxy partnering deals by therapy area 2009-2014

Figure 2: Ranbaxy partnering deals by therapy area 2009-2014

Figure 2: Ranbaxy partnering deals by therapy area 2009-2014

Source: Current Agreements, 2014

Ranbaxy particularly focusses on cosmetics, hair disorders, wound healing and wrinkles in the dermatology therapy focus. This year 2014, Ranbaxy has announced a deal with Epirus Biopharmaceuticals for the biosimilar compound BOWO15 to treat rheumatoid arthritis.

Further analysis of these deals shows that Ranbaxy has a preference for licensing, marketing and distribution deals. Such partnering deals provide the right for Ranbaxy to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Ranbaxy based on deal type disclosed.

Figure 3: Ranbaxy partnering deals by deal type 2009-2014

Figure 3: Ranbaxy partnering deals by deal type 2009-2014

Source: Current Agreements, 2014

When looking at stage of development at partnering deal signing, the most popular stage at signing is marketed with 9 deal announcements.

The following table provides an overview of the partnering deals announced by Ranbaxy based on stage of development at signature.                                                                                                       

Figure 4: Ranbaxy partnering by stage of development 2009-2014

Figure 4: Ranbaxy partnering by stage of development 2009-2014

Figure 4: Ranbaxy partnering by stage of development 2009-2014

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal.

Report: Partnering Agreements with Ranbaxy 2009-2014

Ranbaxy partnering at Current Agreements

View all partnering deals for Ranbaxy: 2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Report: Partnering Agreements with Ranbaxy 2009-2014

More 

Summary profile data for Ranbaxy 

Partnering interests for Ranbaxy

No M&A activity for Ranbaxy since 2009

 

Available reports from Current Partnering 

Report: Partnering Agreements with Ranbaxy 2009-2014

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Ranbaxy

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more 

Read: more on Ranbaxy company profile, recent partnering, M&A and financing news and articles

 

Related 

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply